GABRIELLE FERNANDEZ: Open Payments
NPI 1851792303 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 19 payments from 6 companies in 2025. Trend: 2023 $321 · 2024 $387 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $135 |
| SANOFI-AVENTIS U.S. LLC | 2 | $69 |
| Dexcom, Inc. | 4 | $62 |
| Abbott Laboratories | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $15 |
Products named: TZIELD, Dexcom G6 Transmitter, Wegovy, FREESTYLE LIBRE 3, Rybelsus, Ozempic, GVOKE HYPOPEN, Korlym.
Industry payments across SC — which companies pay providers there.
